Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Phylogica
Phylogica
Activities:
Ingredients
Research & Development
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Phylogica signs deal with UK biotech to identify and develop cancer drugs
Takes a 7.5% stake in PhoreMost, based in Cambridge
Research & Development
Phylogica enters into research and licensing agreement with Genentech
Perth, Australia-based company will receive an upfront payment of US$500,000
Research & Development
Phylogica expands peptide drug conjugates pact with Janssen
Australian firm has received an undisclosed payment to fund additional research
Research & Development
Phylogica enters peptide agreement with Janssen Biotech
To identify cell-penetrating Phylomer peptides
Research & Development
Phylogica forms target discovery spin-off
Sets up new venture called Phenomica with University of Cambridge in the UK
Research & Development
Phylogica completes first stage of collaboration with Roche
Receives undisclosed milestone payment
Research & Development
Phylogica to collaborate with Pfizer
To discover novel peptide-based vaccines
Subscribe now